U.S. Customs and Border Protection introduced a web-based ACE Portal application for companies without existing access. The new form speeds up account setup, updates, and communication with CBP. Legacy PDF submissions remain available during the transition, supporting businesses needing multiple Importer of Record numbers or other special cases.
New U.S. Section 232 pharmaceutical tariffs introduce a 100% duty on patented drugs and APIs beginning in 2026, with tiered rates tied to onshoring and pricing agreements. While generics and specialty medicines remain exempt, companies can reduce tariffs to 0% through MFN pricing and domestic manufacturing commitments, signaling a major shift in global pharmaceutical supply chains and U.S. trade policy.
Canada’s January 2026 Export Control List Guide takes effect May 1, 2026, following a 30-day transition for NEXCOL users. The update aligns Canada’s export controls with international commitments and lets exporters review classifications, permit requirements, and internal compliance before the new guide takes effect.
Established in 1901, GHY International is a leading trade and brokerage services provider that offers acclaimed support and guidance to North American companies that trade internationally.
Proud to partner with Canadian Manufacturers & Exporters.
Copyright © GHY International | Geo. H. Young & Co. Ltd.